The Covid-19 Study with Ayurveda add-on to ICMR Guideline

An Open-labeled black box clinical study to investigate efficacy of add on personalized Ayurveda intervention in comparison to standalone treatment based on ICMR guidelines in patients with COVID-19 - CSAICMR

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026337

Enrollment

Registered

2020-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Add-on personalised Ayurveda intervention to ICMR Guideline on Covid-19: Observing the clinical course of COVID 19, epistemologically it fits into the algorithm of Vatakapha pradhana Sa

Eligibility

Inclusion criteria

Inclusion criteria: (i) Confirmed case of COVID case with RT-PCR method at a stage when not requiring ventilator or Intensive Care Unit support (ii) Aged above 18 years willing to give informed consent. (iii) Preferably those with Diabetes Mellitus Type II as co-morbidity. (iv) X ray Chest Changes more than 20% of Lung involvement.

Exclusion criteria

Exclusion criteria: Co-morbidities like acute and advanced stage of chronic obstructive pulmonary disease, malignancy, chronic liver diseases, recent history of cardiovascular events, renal diseases, acute inflammatory complications of diabetes like non-healing ulcers and severe neuropathy.

Design outcomes

Primary

Measure	Time frame
Primary outcome measures 1. Alleviate form the symptoms of the COVID-19 2. Average stay at the hospital till PCR test becomes normal 3. Reduction in the rate of mild to severe condition requiring ICU or ventilator Timepoint: Day 0 Day 3 Day 7 Day 11 Day 14	—

Secondary

Measure	Time frame
Secondary outcome measures 1. Changes in Haematological and Biochemical parameter like CBC, ESR, CRP, Liver function test, Renal function test, CPK, Prothrombin time 2. Changes in inflammatory markers IL6, FerritinTimepoint: Day 0 Day 3 Day 7 Day 11 Day 14	—

Countries

India

Contacts

Public ContactSujith Subash Eranezhath

AVP Research Foundation

cso@avpresearch.org9790502037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026